Yildirim, D. Et Al. 2022. DO IL-1 ANTAGONISTS DEFINITELY PROTECT FROM THE DEVELOPMENT OF NEW DAMAGE: A SINGLE-CENTER STUDY. ANNALS OF THE RHEUMATIC DISEASES , vol.81 , 1001-1002.

Yildirim, D., Kardas, R. C., Ozkiziltas, B., Vasi, I., KÜÇÜK, H., ÖZTÜRK, A. M., ... Haznedaroglu, S.(2022). DO IL-1 ANTAGONISTS DEFINITELY PROTECT FROM THE DEVELOPMENT OF NEW DAMAGE: A SINGLE-CENTER STUDY. ANNALS OF THE RHEUMATIC DISEASES , vol.81, 1001-1002.

Yildirim, D. Et Al. "DO IL-1 ANTAGONISTS DEFINITELY PROTECT FROM THE DEVELOPMENT OF NEW DAMAGE: A SINGLE-CENTER STUDY," ANNALS OF THE RHEUMATIC DISEASES , vol.81, 1001-1002, 2022

Yildirim, D. Et Al. "DO IL-1 ANTAGONISTS DEFINITELY PROTECT FROM THE DEVELOPMENT OF NEW DAMAGE: A SINGLE-CENTER STUDY." ANNALS OF THE RHEUMATIC DISEASES , vol.81, pp.1001-1002, 2022

Yildirim, D. Et Al. (2022) . "DO IL-1 ANTAGONISTS DEFINITELY PROTECT FROM THE DEVELOPMENT OF NEW DAMAGE: A SINGLE-CENTER STUDY." ANNALS OF THE RHEUMATIC DISEASES , vol.81, pp.1001-1002.

@article{article, author={D. Yildirim Et Al. }, title={DO IL-1 ANTAGONISTS DEFINITELY PROTECT FROM THE DEVELOPMENT OF NEW DAMAGE: A SINGLE-CENTER STUDY}, journal={ANNALS OF THE RHEUMATIC DISEASES}, year=2022, pages={1001-1002} }